ME/CFS Linked to Reduced Bioactive Cortisol and Heightened Feedback Sensitivity

The Neuroendocrine Underpinnings of Chronic Fatigue

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) remains a significant clinical challenge, with a global prevalence estimated between 0.89% and 2.5% [1, 2, 3]. Patients typically present with a core clinical triad of persistent fatigue, unrefreshing sleep, and post-exertional malaise, which is the pathognomonic worsening of symptoms following even minor physical or cognitive exertion [3]. While the International Consensus Criteria have standardized the diagnostic process, the underlying pathophysiology remains a subject of intense investigation involving neuroinflammation, immune dysregulation, and chronic stress maladaptation [4, 5, 6]. Central to this debate is the hypothalamic-pituitary-adrenal (HPA) axis, the primary neuroendocrine system regulating the physiological stress response. Previous research has identified significant basal hypocortisolism in patients with ME/CFS, with a standardized mean difference of -0.14 (p=0.047) [7]. Furthermore, meta-analytic data indicate an attenuation of the cortisol awakening response increase, which is the expected sharp rise in cortisol levels immediately upon waking, with an effect size of d=-0.34 [8]. A new meta-analysis now clarifies these neuroendocrine discrepancies by identifying a specific signature of cortisol deficiency and feedback sensitivity in this patient population.

Meta-Analytic Evidence Across Diverse Cortisol Matrices

To resolve long-standing inconsistencies in the neuroendocrine literature, researchers conducted a comprehensive systematic review and meta-analysis of 46 case-control studies comprising 46 independent datasets. This large-scale analysis included a total study population of 1388 patients with ME/CFS and 1349 matched healthy controls, providing the statistical power necessary to identify subtle but consistent hormonal patterns. The patient cohort reflected the typical clinical demographic for this condition, as the group was 71.9% female with a mean age of 37.3 ± 6.2 years. By aggregating data across diverse measurement methods, the study aimed to establish whether cortisol deficiencies were transient fluctuations or a stable systemic feature of the disorder. This approach addresses the inherent variability in cortisol secretion, which can be influenced by circadian rhythms and acute stressors, by looking for a unified signal across different biological tissues.

Adrenal Insufficiency and Enhanced Feedback Sensitivity

The meta-analysis demonstrated a clear trend of reduced bioactive cortisol across multiple biological matrices, suggesting a state of chronic HPA-axis hyporeactivity. Specifically, patients with ME/CFS exhibited lower salivary cortisol levels at awakening and lower salivary cortisol levels in the morning compared to healthy controls. These findings were further supported by reductions in 24-hour urinary cortisol levels, which provide an integrated measure of total daily hormone production rather than a single time-point snapshot. Perhaps most notably, the researchers observed reductions in hair cortisol levels in the ME/CFS cohort. Hair cortisol serves as a biomarker of long-term systemic cortisol exposure over several months, much like hemoglobin A1c reflects long-term glucose control. The consistency of these findings across different tissues and timeframes reinforces the hypothesis that ME/CFS is characterized by a sustained reduction in cortisol availability. To evaluate the dynamic responsiveness of the endocrine system, the meta-analysis incorporated data from 12 pharmacological challenge studies. These investigations utilized provocative testing to assess how the HPA axis responds to chemical signals. The researchers found that patients with ME/CFS exhibit impaired cortisol release in response to adrenocorticotropic hormone (ACTH) stimulation, the pituitary hormone responsible for signaling the adrenal glands to produce cortisol. This blunted adrenal response suggests a primary or secondary insufficiency in the gland's ability to mobilize resources, contributing to a systemic hyporeactive endocrine state.

Clinical Correlation and Therapeutic Implications

The study further identified a mechanism of enhanced HPA-axis negative feedback sensitivity through the use of glucocorticoid suppression tests. In these challenges, patients demonstrated exaggerated cortisol suppression following glucocorticoid administration, indicating that their internal regulatory thermostat is hypersensitive to circulating hormones. This hypersensitivity causes the HPA axis to shut down hormone production prematurely, leading to reduced free cortisol availability, or bioactive cortisol, in the bloodstream. For the practicing physician, this neuroendocrine signature provides a biological framework for the severe fatigue, cognitive slowing, and diminished stress resilience that define the ME/CFS clinical presentation. These findings suggest that the inability of the HPA axis to maintain adequate bioactive cortisol levels directly correlates with the systemic inability of patients to recover from physical or mental exertion. Beyond physical exhaustion, the observed endocrine state may contribute to the neuropsychiatric and cognitive symptoms frequently reported in clinical practice. The researchers noted that reduced cortisol availability likely facilitates cognitive slowing, emotional blunting, and diminished stress resilience, which are common manifestations of impaired stress recovery. This suggests that the cognitive impairment and unrefreshing sleep seen in ME/CFS are not merely secondary symptoms but are potentially driven by the same HPA-axis dysfunction that limits physical energy. Integrating neuroendocrine and psychological perspectives may clarify the mechanisms of chronic stress maladaptation, a process where the body's stress-response systems become fixed in a dysfunctional, low-output state. Ultimately, these findings may inform future psychobiological interventions for fatigue syndromes, shifting the therapeutic focus toward strategies that aim to restore HPA-axis homeostasis and improve the physiological response to stressors.

References

1. Lim E, Ahn Y, Jang E, Lee S, Lee S, Son C. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Journal of Translational Medicine. 2020. doi:10.1186/s12967-020-02269-0

2. López-Amador N. An integrative review on the orexin system and hypothalamic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: implications for precision medicine. Exploration of Neuroprotective Therapy. 2025. doi:10.37349/ent.2025.1004112

3. Carruthers BM, Sande MIVD, Meirleir KLD, et al. Myalgic encephalomyelitis: International Consensus Criteria. Journal of Internal Medicine. 2011. doi:10.1111/j.1365-2796.2011.02428.x

4. Lawrence JM, Schardien KA, Wigdahl B, Nonnemacher MR. Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathologica Communications. 2023. doi:10.1186/s40478-023-01526-9

5. Cui L, Li S, Wang S, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduction and Targeted Therapy. 2024. doi:10.1038/s41392-024-01738-y

6. Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Molecular Psychiatry. 2015. doi:10.1038/mp.2015.67

7. Tak LM, Cleare AJ, Ormel J, et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders.. Biological psychology. 2011. doi:10.1016/j.biopsycho.2011.02.002

8. Powell D, Liossi C, Moss‐Morris R, Schlotz W. Unstimulated cortisol secretory activity in everyday life and its relationship with fatigue and chronic fatigue syndrome: a systematic review and subset meta-analysis.. Psychoneuroendocrinology. 2013. doi:10.1016/j.psyneuen.2013.07.004